200 related articles for article (PubMed ID: 9442979)
21. Primary Cutaneous Polymorphic EBV-Associated Posttransplant Lymphoproliferative Disorder After a Renal Transplant and Review of the Literature.
Ferguson NN; Thomas CP; Hohl RJ; Syrbu SI; Stone MS; Wanat KA
Am J Dermatopathol; 2015 Oct; 37(10):790-4. PubMed ID: 25747810
[TBL] [Abstract][Full Text] [Related]
22. CNI withdrawal for post-transplant lymphoproliferative disorders in kidney transplant is an independent risk factor for graft failure and mortality.
Rabot N; Büchler M; Foucher Y; Moreau A; Debiais C; Machet MC; Kessler M; Morelon E; Thierry A; Legendre C; Rivalan J; Kamar N; Dantal J
Transpl Int; 2014 Sep; 27(9):956-65. PubMed ID: 24964147
[TBL] [Abstract][Full Text] [Related]
23. [Diffuse lymphoproliferative disease after renal transplantation and its relation with Epstein-Barr virus. Experience at one center].
Franco A; Jiménez L; Aranda I; Alvarez L; González M; Rocamora N; Olivares J
Nefrologia; 2002; 22(5):463-9. PubMed ID: 12497748
[TBL] [Abstract][Full Text] [Related]
24. Lymphoproliferative disorders after renal transplantation: role of medical imaging.
Claudon M; Kessler M; Champigneulle J; Lefevre F; Hestin D; Renoult E
Eur Radiol; 1998; 8(9):1686-93. PubMed ID: 9866789
[TBL] [Abstract][Full Text] [Related]
25. Sirolimus-induced remission of posttransplantation lymphoproliferative disorder.
Cullis B; D'Souza R; McCullagh P; Harries S; Nicholls A; Lee R; Bingham C
Am J Kidney Dis; 2006 May; 47(5):e67-72. PubMed ID: 16632009
[TBL] [Abstract][Full Text] [Related]
26. Post-transplantation lymphoproliferative disorder in pediatric kidney-transplant recipients - a national study.
Cleper R; Ben Shalom E; Landau D; Weissman I; Krause I; Konen O; Rahamimov R; Mor E; Bar-Nathan N; Frishberg Y; Davidovits M
Pediatr Transplant; 2012 Sep; 16(6):619-26. PubMed ID: 22708682
[TBL] [Abstract][Full Text] [Related]
27. A single-centre experience of post-renal transplant lymphoproliferative disorder.
Herzig KA; Juffs HG; Norris D; Brown AM; Gill D; Hawley CM; Cobcroft R; Petrie JB; Marlton P; Thomson D; Campbell SB; Nicol DL; Johnson DW
Transpl Int; 2003 Jul; 16(7):529-36. PubMed ID: 12734646
[TBL] [Abstract][Full Text] [Related]
28. Is posttransplant lymphoproliferative disorder (PTLD) caused by any specific immunosuppressive drug or by the transplantation per se?
Birkeland SA; Hamilton-Dutoit S
Transplantation; 2003 Sep; 76(6):984-8. PubMed ID: 14508366
[TBL] [Abstract][Full Text] [Related]
29. Primary CNS lymphoproliferative disease, mycophenolate and calcineurin inhibitor usage.
Crane GM; Powell H; Kostadinov R; Rocafort PT; Rifkin DE; Burger PC; Ambinder RF; Swinnen LJ; Borowitz MJ; Duffield AS
Oncotarget; 2015 Oct; 6(32):33849-66. PubMed ID: 26460822
[TBL] [Abstract][Full Text] [Related]
30. Post-transplant lymphoproliferative disorder--the potential of proliferation signal inhibitors.
Pascual J
Nephrol Dial Transplant; 2007 May; 22 Suppl 1():i27-35. PubMed ID: 17456616
[TBL] [Abstract][Full Text] [Related]
31. Posttransplantation lymphoproliferative disorder in a renal allograft recipient.
Goral S; Felgar R; Shappell S
Am J Kidney Dis; 1997 Aug; 30(2):301-7. PubMed ID: 9261047
[TBL] [Abstract][Full Text] [Related]
32. Post-transplant lymphoproliferative disorders after live donor renal transplantation.
Jain M; Badwal S; Pandey R; Srivastava A; Sharma RK; Gupta RK
Clin Transplant; 2005 Oct; 19(5):668-73. PubMed ID: 16146560
[TBL] [Abstract][Full Text] [Related]
33. Posttransplantation lymphoproliferative disease: proposed imaging classification.
Camacho JC; Moreno CC; Harri PA; Aguirre DA; Torres WE; Mittal PK
Radiographics; 2014; 34(7):2025-38. PubMed ID: 25384299
[TBL] [Abstract][Full Text] [Related]
34. [Post-transplant lymphoproliferative disease in liver transplant recipients--Merkur University Hospital single center experience].
Filipec-Kanizaj T; Budimir J; Colić-Cvrlje V; Kardum-Skelin I; Sustercić D; Naumovski-Mihalić S; Mrzljak A; Kolonić SO; Sobocan N; Bradić T; Dolić ZM; Kocman B; Katicić M; Zidovec-Lepej S; Vince A
Acta Med Croatica; 2011 Sep; 65 Suppl 1():37-43. PubMed ID: 23126028
[TBL] [Abstract][Full Text] [Related]
35. Association of the type of induction immunosuppression with posttransplant lymphoproliferative disorder, graft survival, and patient survival after primary kidney transplantation.
Cherikh WS; Kauffman HM; McBride MA; Maghirang J; Swinnen LJ; Hanto DW
Transplantation; 2003 Nov; 76(9):1289-93. PubMed ID: 14627905
[TBL] [Abstract][Full Text] [Related]
36. Rising incidence of post-transplant lymphoproliferative disease in kidney transplant recipients.
Libertiny G; Watson CJ; Gray DW; Welsh KI; Morris PJ
Br J Surg; 2001 Oct; 88(10):1330-4. PubMed ID: 11578286
[TBL] [Abstract][Full Text] [Related]
37. Increased risk for posttransplant lymphoproliferative disease in recipients of liver transplants with hepatitis C.
McLaughlin K; Wajstaub S; Marotta P; Adams P; Grant DR; Wall WJ; Jevnikar AM; Rizkalla KS
Liver Transpl; 2000 Sep; 6(5):570-4. PubMed ID: 10980055
[TBL] [Abstract][Full Text] [Related]
38. Isolated cerebral post-transplant lymphoproliferative disorder in a lymphoma recipient.
Tang TC; Chuang WY; Chang H
J Cancer Res Ther; 2013; 9(3):534-6. PubMed ID: 24126003
[TBL] [Abstract][Full Text] [Related]
39. Posttransplantation lymphoproliferative disorder in children: clinical, histopathologic, and imaging features.
Pickhardt PJ; Siegel MJ; Hayashi RJ; Kelly M
Radiology; 2000 Oct; 217(1):16-25. PubMed ID: 11012419
[TBL] [Abstract][Full Text] [Related]
40. A Solid Mass in the Chest Wall.
Alagoz S; Yalin SF; Gulcicek S; Ozgur N; Altiparmak MR; Seyahi N
Prog Transplant; 2016 Dec; 26(4):386-388. PubMed ID: 27555070
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
